Oncology
Novel targeted therapies, immuno-oncology, supportive care
Business development
Open to partnerships.
Exclusive distribution and in-licensing across the full spectrum of human healthcare.
Partnership types
Ribicon Pharma actively seeks exclusive distribution and in-licensing agreements with innovative companies across the full spectrum of human healthcare. We bring commercial infrastructure, regulatory expertise, and established market access in MENA and Canada.
- Exclusive Distribution
- In-Licensing
- Co-Promotion
- Market Access
- Regulatory Support
- KOL Access
What we are looking for
Therapeutic areas we are seeking
Hematology
Rare blood disorders, HSCT conditioning, bone marrow failure
Rare Diseases
Orphan drugs, enzyme replacement, gene therapy
Ophthalmology
Novel glaucoma, retinal, and ocular surface therapies
Cardiology
Cardiac monitoring devices, heart failure, diagnostics
Neurology
CNS disorders, MS, neurodegenerative diseases
OTC & Food
Supplements, medical foods, consumer health brands
Medical Devices
Diagnostic devices, patient monitoring, MIS tools